Larvol Delta - Alterity-Therapeutics-has-secured-a-new-US-Composition-of-Matter-patent-covering-its-lead-drug-candidate-ATH434-extending-intellectual-property-IP-protection-for-the-potential-neurodegenerative-disease-treatment-to-at-least-2045

ATH434 - Alterity Therap

https://www.theaustralian.com.au/business/stockhead/content/alterity-strengthens-ip-with-new-us-patent-for-ath434-ahead-of-phase-iii-msa-trial/news-story/3f6dddfb69aff5a00d3099fef4b24d6b

Aug 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next